
Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer
Proven Pharmaceutical Executive Brings Over 30 Years of R&D Experience to Supercharge the Company’s Next Phase of Growth Seasoned Biotechnology Leader Mike Varney, Ph. D., Appointed as Lead Independent Director of the Board Press Release – SAN FRANCISCO, CALIFORNIA, FEBRUARY 18, 2025 – Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve … Continue reading Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer